Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 114.79 million as of January 22, 2026. Its market cap has increased by 459.17% in one year.

Market Cap

114.79M

Enterprise Value

126.64M

Revenue

30.29M

Ranking

n/a

PE Ratio

n/a

Stock Price

10.92

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 114.79M, a decrease of -32.39%. That is a compound annual growth rate of -3.87%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2026	114.26M	9.25%
Dec 31, 2025	104.59M	395.31%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Feb 26, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haleon	32.16B
Hikma Pharmaceuticals	3.42B
HUTCHMED (China)	1.93B
Allergy Therapeutics	718.55M
Animalcare Group	175.38M
Animalcare Group	175.38M
Venture Life Group	80.27M
ECO Animal Health Group	72.16M

Market Cap Rankings